ImmuCell Corporation
ICCC
$6.20
-$0.05-0.80%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 143.51% | 93.03% | 62.65% | 39.53% | 32.71% |
| Total Depreciation and Amortization | -0.76% | -1.15% | -1.10% | 1.58% | 5.25% |
| Total Amortization of Deferred Charges | 8.54% | 39.81% | 88.50% | 190.97% | 423.68% |
| Total Other Non-Cash Items | -70.65% | -58.70% | -59.55% | -44.06% | -1.26% |
| Change in Net Operating Assets | -404.25% | -47.85% | 80.75% | 122.18% | 123.11% |
| Cash from Operations | 1,198.40% | 201.30% | 107.66% | 93.10% | 96.16% |
| Capital Expenditure | -12.59% | 43.44% | 75.39% | 89.37% | 81.11% |
| Sale of Property, Plant, and Equipment | 323.19% | 80.00% | 80.00% | 80.00% | 6,800.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 200.00% | -- |
| Cash from Investing | -9.39% | 43.68% | 75.60% | 93.23% | 81.30% |
| Total Debt Issued | -- | -- | -- | -100.00% | 300.00% |
| Total Debt Repaid | 55.87% | 54.88% | 53.91% | 52.85% | -249.72% |
| Issuance of Common Stock | 987.19% | 25,603.19% | 25,500.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -43.14% | -477.57% | -466.38% | -56.17% | -- |
| Cash from Financing | 270.93% | 347.17% | 64.60% | 32.22% | 2,957.87% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3,695.46% | 270.39% | 157.75% | 126.60% | 98.64% |